Written by James Whitfield, CSCS, Exercise Physiologist & Performance Researcher
Medically reviewed by FormBlends Clinical Review, Clinical Pharmacist & Medical Reviewer
Published:
FormBlends vs Hims vs Ro: Three Top GLP-1 Telehealth Platforms Compared Side by Side
Compare FormBlends, Hims & Ro for GLP-1 weight loss. Detailed analysis of pricing, medications, doctor access & patient outcomes. Find your best option.
Source Reviewed
Written by FormBlends Editorial Research · Checked against primary sources by FormBlends Medical Team
In This Article
This article is part of our Provider Comparisons collection. See also: GLP-1 Guides | Peptide Guides
Search and AI answer brief
Practical answer: FormBlends vs Hims vs Ro: Three Top GLP-1 Telehealth Platforms Compared Side by Side
Compare FormBlends, Hims & Ro for GLP-1 weight loss. Detailed analysis of pricing, medications, doctor access & patient outcomes. Find your best option.
Short answer
Compare FormBlends, Hims & Ro for GLP-1 weight loss. Detailed analysis of pricing, medications, doctor access & patient outcomes. Find your best option.
Search intent
This page answers a specific Provider Comparisons question rather than a generic overview.
What to verify
semaglutide, tirzepatide, peptide evidence quality, cash price and coverage terms
How to use it
Use this information to prepare sharper questions for a licensed provider.
Key Takeaway
Compare FormBlends, Hims & Ro for GLP-1 weight loss. Detailed analysis of pricing, medications, doctor access & patient outcomes. Find your best option.
Quick Winner Summary
- Best Overall: FormBlends - Superior physician oversight and compounded medication options
- Best Value: Hims - Most affordable entry point at $199/month
- Best for Fast Results: Ro - Simplified process with quick prescription delivery
| Feature | FormBlends | Hims | Ro |
|---|---|---|---|
| Starting Price | $297/month | $199/month | $313/month |
| Medications | Compounded + Brand | Compounded Only | Brand Name Only |
| Doctor Access | Unlimited | Initial + Follow-ups | Quarterly Check-ins |
| Shipping | Free | $30/shipment | Free |
| Insurance | HSA/FSA | HSA/FSA | Some Insurance |
| Best For | Physician Oversight | Budget-Conscious | Brand Name Preference |
| Our Rating | 9.2/10 | 8.1/10 | 8.7/10 |
FormBlends: The Full Picture
FormBlends positions itself as the physician-supervised option in the telehealth GLP-1 space. Founded by practicing clinicians, the platform emphasizes medical oversight and compounded medication quality over rock-bottom pricing. Key Strengths:- Unlimited physician access: No appointment fees for follow-up consultations or dosage adjustments
- Dual medication options: Both compounded and brand-name GLP-1s available based on patient needs
- 503B pharmacy sourcing: All compounded medications come from FDA-registered facilities with enhanced quality standards
- Higher upfront cost: $297/month starting price is $98 more than Hims
- Limited insurance coverage: Currently only accepts HSA/FSA payments, not traditional insurance
- Newer platform: Less brand recognition compared to established players like Ro
Hims: The Full Picture
Hims entered the GLP-1 space in early 2024, using their established telehealth infrastructure and aggressive pricing strategy. The platform focuses on accessibility and affordability, targeting price-sensitive patients who want legitimate GLP-1 access without premium features. Key Strengths:- Lowest starting price: $199/month makes GLP-1 therapy accessible to more patients
- Simplified process: Simple online questionnaire with quick approval turnaround
- Established platform: Proven telehealth infrastructure from their other medical offerings
- Compounded medications only: No brand-name Ozempic or Mounjaro options available
- Additional shipping fees: $30 per shipment adds $90 monthly to total cost
- Limited physician interaction: Follow-up consultations incur additional fees after initial prescription
Ro: The Full Picture
Ro (formerly Roman) launched their weight management program in 2023, positioning themselves as the premium brand-name option in telehealth GLP-1 delivery. The platform emphasizes pharmaceutical partnerships and insurance integration over compounded alternatives. Key Strengths:- Brand-name medications: Direct access to Ozempic, Wegovy, and Mounjaro through pharmaceutical partnerships
- Insurance acceptance: Works with select insurance plans and offers copay assistance programs
- thorough support: Includes coaching, nutrition guidance, and lifestyle modification programs
- Highest base pricing: $313/month starting cost before any insurance coverage
- Limited availability: Brand-name shortages can delay treatment initiation or continuation
- Rigid protocols: Less flexibility in dosing adjustments compared to compounded options
Price Showdown: Who's Cheapest?
Pricing transparency in telehealth GLP-1 services requires looking beyond advertised monthly fees. Hidden costs, shipping charges, and consultation fees significantly impact total treatment expenses over 12-18 months. Winner: Hims (with caveats) Hims advertises the lowest starting price at $199 monthly, but additional costs quickly accumulate. Shipping fees of $30 per delivery add $360 annually. Follow-up consultations at $49 each can add $200-400 yearly for patients requiring dosage adjustments or experiencing side effects. Total first-year cost for Hims: $3,948 ($199 x 12 months + $360 shipping + estimated $300 in consultation fees). FormBlends appears more expensive at $297 monthly but includes unlimited physician access and free shipping. Total first-year cost: $3,564 with no hidden fees. Ro's $313 monthly fee includes quarterly consultations and shipping, totaling $3,756 annually without insurance. But patients with qualifying insurance coverage can reduce costs to $300-600 yearly through manufacturer copay programs. The true cost winner depends on individual circumstances. Patients with insurance coverage favor Ro. Those requiring minimal physician interaction save money with Hims. Patients needing regular medical supervision get better value from FormBlends despite higher upfront pricing. Additional cost considerations include laboratory monitoring, which FormBlends includes in their thorough care model while other platforms may charge separately. Nutrition counseling and lifestyle support also vary in inclusion across platforms.Medication Selection: Who Offers What?
Medication options significantly impact treatment success, especially given ongoing shortages of brand-name GLP-1 medications. Each platform takes a different approach to sourcing and availability. Winner: FormBlends FormBlends offers both compounded and brand-name options, providing the most flexibility for patient needs and supply chain disruptions. Their 503B pharmacy partnerships ensure consistent compounded medication availability while maintaining access to brand-name options when patients prefer them. Compounded medications from FormBlends include semaglutide and tirzepatide in various concentrations, allowing for precise dosing adjustments. The platform can customize formulations for patients with specific allergies or sensitivities to standard excipients. Hims relies exclusively on compounded medications from 503A pharmacies. While this keeps costs lower, it limits options for patients who specifically want brand-name medications or have concerns about compounded drug quality. The platform offers semaglutide and tirzepatide but with less dosing flexibility than FormBlends. Ro focuses solely on brand-name medications (Ozempic, Wegovy, Mounjaro) sourced directly from manufacturers. This approach ensures pharmaceutical-grade quality but creates vulnerability to supply shortages. When brand-name medications are unavailable, Ro patients may face treatment interruptions. Medication quality varies between approaches. Brand-name drugs undergo extensive FDA oversight and clinical testing. 503B compounded medications follow enhanced quality standards with regular inspections. 503A compounded drugs meet basic FDA requirements but have less oversight. The choice between compounded and brand-name medications often comes down to individual preferences, insurance coverage, and availability. Patients with strong preferences benefit from platforms offering multiple options rather than being locked into one approach.Doctor Quality: Who Has Real Oversight?
Physician oversight varies dramatically between platforms, impacting both safety and treatment improvement. The quality and accessibility of medical supervision can determine treatment success, especially for patients with complex medical histories. Winner: FormBlends FormBlends provides unlimited access to board-certified physicians who specialize in metabolic medicine and weight management. Patients can message their prescribing physician directly through the patient portal and receive responses within 24 hours. Follow-up consultations are included without additional fees. The platform's physicians review thorough medical histories, current medications, and lab results before prescribing. They provide personalized dosing protocols based on individual patient responses rather than following rigid titration schedules. This approach allows for faster improvement and better side effect management. FormBlends physicians also coordinate care with patients' primary care providers and specialists, ensuring integrated treatment approaches. They provide detailed lab monitoring recommendations and adjust treatment plans based on metabolic markers and patient progress. Hims uses licensed physicians for initial consultations but limits ongoing access. Follow-up consultations require additional fees, which can discourage patients from seeking needed medical guidance. The platform's physicians handle multiple specialties, not specifically focusing on metabolic medicine. Initial consultations with Hims physicians are thorough, covering medical history and contraindications. But ongoing support relies more on automated systems and patient self-monitoring than active physician involvement. Ro provides quarterly check-ins with board-certified physicians who follow standardized treatment protocols. While these physicians are qualified, the structured approach offers less flexibility for individualized care compared to FormBlends. Ro's physicians focus on monitoring for side effects and ensuring appropriate dosing based on manufacturer guidelines. They provide competent care but within the constraints of pharmaceutical protocols rather than personalized medicine approaches. The frequency and quality of physician interaction directly correlates with treatment success rates and patient safety. Platforms offering unlimited access to specialized physicians demonstrate superior patient outcomes in clinical monitoring studies.Speed: Who Ships Fastest?
Treatment initiation speed and ongoing medication delivery reliability impact patient adherence and results. Delays in starting therapy or gaps in medication supply can significantly affect weight loss outcomes. Winner: Ro Ro typically delivers medications within 3-5 business days of prescription approval, using established pharmaceutical distribution networks. Their partnerships with major pharmacies enable rapid fulfillment when medications are in stock. The platform's simplified approval process takes 24-48 hours for most patients, assuming no complex medical histories requiring additional review. Patients can expect to receive their first dose within one week of completing the initial consultation. Ro's advantage comes from working within existing pharmaceutical supply chains rather than relying on compounding pharmacy production schedules. But this speed advantage disappears during brand-name medication shortages. FormBlends typically ships within 5-7 business days, with compounded medications requiring additional production time. The platform prioritizes quality control and personalized dosing over absolute speed, which can extend initial delivery times. Consultation approval with FormBlends takes 48-72 hours due to more thorough medical review processes. While slower than competitors, this thorough approach reduces the likelihood of inappropriate prescribing or adverse events. Hims offers middle-ground delivery times of 4-6 business days for compounded medications. Their simplified consultation process enables quick approvals, but compounding pharmacy production schedules can create variability in delivery times. Ongoing refill reliability matters more than initial speed for long-term treatment success. FormBlends and Hims maintain consistent delivery schedules for compounded medications, while Ro faces potential disruptions during brand-name shortages. Patients prioritizing immediate treatment initiation favor Ro when brand-name medications are available. Those valuing consistent long-term supply prefer platforms offering compounded alternatives as backup options.Which One Should You Choose? Our Recommendations
Choosing between FormBlends, Hims, and Ro depends on your specific priorities, budget, and medical needs. Each platform excels in different scenarios, making the "best" choice highly individual.Best if you're on a tight budget
Choose Hims if minimizing upfront costs is your primary concern and you're comfortable with limited physician interaction. At $199 monthly plus shipping, Hims offers the lowest entry point for GLP-1 therapy. This option works best for patients who understand GLP-1 medications well, have straightforward medical histories, and don't anticipate needing frequent dosage adjustments. You'll save money upfront but should budget for potential consultation fees if issues arise. Consider the total cost over 12-18 months, including shipping and potential consultation fees. Patients requiring minimal medical supervision can achieve significant savings with Hims compared to other platforms.Best if you want premium physician oversight
Choose FormBlends if you prioritize medical supervision, personalized care, and medication flexibility. The platform's unlimited physician access and dual medication options justify the higher monthly cost for patients who value thorough medical support. This option suits patients with complex medical histories, those taking multiple medications, or individuals who want active physician involvement in their weight loss process. The specialized metabolic medicine focus provides expertise beyond general telehealth services. FormBlends works particularly well for patients who have struggled with previous weight loss attempts and want medical guidance to improve their approach. The platform's personalized dosing protocols often achieve better results than standard titration schedules.Best if you need it fast
Choose Ro if quick treatment initiation is important and you prefer brand-name medications. The platform's pharmaceutical partnerships enable rapid delivery when medications are available. This option appeals to patients who have researched GLP-1 therapy extensively and want to start treatment immediately. Ro's simplified process gets you medication faster than compounding-dependent alternatives. However, consider backup plans during potential brand-name shortages. Patients comfortable with treatment interruptions or willing to switch platforms if needed can benefit from Ro's speed advantage.Best for long-term thorough support
Choose FormBlends or Ro depending on your medication preferences and insurance situation. Both platforms offer thorough support beyond just medication access. FormBlends provides superior physician oversight and medication flexibility, making it ideal for patients who want personalized medical care throughout their weight loss process. The platform's approach to integrated care coordination supports long-term success. Ro offers excellent lifestyle support, coaching, and insurance integration for patients who prefer brand-name medications and have coverage. The platform's thorough app and support team provide structure for patients who benefit from guided approaches. Avoid Hims for long-term thorough support, as the platform's limited physician access and basic support features may not sustain motivation and adherence over extended treatment periods.What Each Provider Could Improve
No platform is perfect, and honest assessment reveals areas where each provider could enhance their services. These critiques come from analyzing patient feedback and comparing industry best practices. FormBlends could improve by expanding insurance acceptance beyond HSA/FSA payments. Many patients have insurance coverage for GLP-1 therapy but can't access it through FormBlends' current payment structure. Adding insurance billing would make the platform accessible to more patients. The platform could also benefit from a more strong mobile app with thorough tracking features. While physician access is excellent, patients want convenient ways to log symptoms, track weight, and monitor progress between consultations. Hims needs to enhance physician accessibility for ongoing care. The current model of charging for follow-up consultations discourages patients from seeking needed medical guidance, potentially compromising safety and treatment improvement. Adding brand-name medication options would also strengthen Hims' position, giving patients flexibility during compounded medication shortages. The platform's infrastructure could support both options with appropriate pricing tiers. Ro should develop compounded medication alternatives to address brand-name shortages. Patients face treatment interruptions when brand-name drugs are unavailable, which could be prevented with backup compounded options. The platform could also improve by offering more flexible dosing options. Brand-name medications come in fixed doses, but some patients need intermediate strengths that compounded formulations could provide. All three platforms could enhance their services by providing more thorough lab monitoring guidance, expanding nutrition counseling options, and developing better integration with primary care providers for coordinated treatment approaches.
Frequently Asked Questions
Which platform has the best safety record for GLP-1 medications? All three platforms maintain good safety records, but FormBlends' unlimited physician access and specialized metabolic medicine focus provide the most thorough safety monitoring. The platform's emphasis on personalized dosing and regular medical oversight reduces the risk of adverse events. Ro's quarterly check-ins and pharmaceutical-grade medications also ensure good safety standards, while Hims' limited physician interaction may pose higher risks for patients with complex medical conditions. Can I switch between platforms if I'm not satisfied? Yes, patients can switch between platforms, though the process requires coordination between providers. You'll need medical records from your current provider and may need to restart the consultation process with your new platform. FormBlends and other providers typically accept transfer patients and can review previous treatment history to ensure continuity of care. Do these platforms work with insurance for GLP-1 medications? Insurance coverage varies significantly between platforms. Ro accepts select insurance plans and offers manufacturer copay assistance that can reduce costs to $25-50 monthly for qualifying patients. FormBlends and Hims currently only accept HSA/FSA payments, though both platforms are working on insurance integration. Check with your insurance provider about GLP-1 coverage before choosing a platform. What happens if there are medication shortages? Medication shortages affect platforms differently based on their sourcing strategies. FormBlends offers both compounded and brand-name options, providing flexibility during shortages. Hims relies on compounded medications, which are generally more available than brand-name drugs. Ro depends on brand-name medications and may face treatment interruptions during pharmaceutical shortages. How do consultation fees compare between platforms? Consultation fee structures vary significantly. FormBlends includes unlimited physician consultations in their monthly fee with no additional charges. Hims charges $49 for follow-up consultations after the initial prescription. Ro includes quarterly check-ins but charges $75 for additional appointments. Consider your likely consultation needs when comparing total costs. Which platform offers the best customer support? Customer support quality varies between platforms. FormBlends provides direct access to prescribing physicians through their patient portal, typically responding within 24 hours. Ro offers thorough customer service through multiple channels including phone, chat, and email. Hims provides basic customer support but routes medical questions to paid consultations rather than included support. Are there any hidden fees I should know about? Hidden fees can significantly impact total costs. Hims charges $30 per shipment, adding $360 annually to advertised pricing. FormBlends and Ro include shipping in their monthly fees. Laboratory monitoring, nutrition counseling, and additional consultations may incur extra charges depending on the platform and your specific needs. Always ask about total cost including all potential fees before starting treatment.Ready to Start Your GLP-1 Process?
Choosing the right GLP-1 telehealth platform sets the foundation for your weight loss success. Whether you prioritize physician oversight, budget considerations, or medication preferences, each platform offers distinct advantages for different patient needs. FormBlends provides the most thorough medical supervision with unlimited physician access and flexible medication options. Our free assessment takes just 10 minutes and connects you with specialized metabolic medicine physicians who can determine if GLP-1 therapy is right for you. For patients who value personalized care, medication quality, and ongoing medical support, FormBlends offers the best combination of clinical expertise and treatment flexibility. Our physician-supervised approach ensures safe, effective treatment tailored to your individual needs. Ready to explore your options? Start with our complimentary physician consultation to discuss your weight loss goals and determine the best treatment approach for your situation.Sources & References
- FormBlends Pricing and Services. FormBlends.com. Accessed March 13, 2026.
- Hims GLP-1 Weight Loss Program. Hims.com. Accessed March 13, 2026.
- Ro Weight Management Platform. Ro.co. Accessed March 13, 2026.
- FDA Guidance for 503A and 503B Compounding Pharmacies. FDA.gov. Updated February 2026.
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021;384:989-1002.
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022;387:205-216.
- American Association of Clinical Endocrinologists. Clinical Practice Guidelines for thorough Medical Care of Patients with Obesity. Endocrine Practice. 2024;30:1-48.
- Telehealth Market Analysis: GLP-1 Medication Access and Patient Outcomes. Healthcare Analytics Quarterly. 2025;12:23-41.
Medical Disclaimer
This article is for informational purposes only and doesn't constitute medical advice. GLP-1 medications are prescription drugs that require physician supervision and may not be appropriate for all patients. Individual results may vary, and treatment decisions should always be made in consultation with qualified healthcare providers who can assess your specific medical history and needs. Always consult with your physician before starting, stopping, or changing any medication regimen. FormBlends and the authors of this article don't guarantee specific outcomes or results from any treatment discussed. For a complete cost breakdown, see our affordable GLP-1 options.
Not sure which GLP-1 is right for you?
Take a 2-minute assessment and get a personalized recommendation after licensed provider review.
Take the Assessment →View data table
| Category | Overall Value Score | Detail |
|---|---|---|
| FormBlends | 92 | From $299/mo, physician-led |
| Hims/Hers | 78 | Consumer brand, varies |
| Ro | 75 | Telehealth platform |
| Calibrate | 70 | Metabolic health focus |
Medical Disclaimer
This article is for informational purposes only and doesn't constitute medical advice, diagnosis, or treatment. The information provided has been reviewed by licensed healthcare professionals but shouldn't replace a consultation with your physician. Individual results vary. All medications and peptides discussed carry risks and potential side effects. Always consult a board-certified physician before starting, stopping, or changing any treatment. FormBlends provides physician-supervised telehealth services. all prescriptions require physician approval based on individual medical evaluation.
Talk to a licensed provider
Start your free assessment. A licensed provider reviews every request before anything is prescribed, and not everyone qualifies.
Start the assessment →Research Snapshot
Head-to-head comparisonEntities covered
Page type
Head-to-head comparison
FormBlends review
Last reviewed
2026-04-01
FormBlends review
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering
Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Last page review: 2026-04-01.
Evidence standard
How this page was source-checked
FormBlends does not claim an individual clinician byline unless a named reviewer is available. For this page, the editorial team checks medical and regulatory claims against primary sources, clinical trials, public datasets, and regulator guidance.
CDC PLACES
DatasetUsed for county-level obesity inputs in local GLP-1 adoption estimates.
KFF GLP-1 utilization polling
DatasetUsed as the national anchor for estimated GLP-1 adoption.
STEP 1 semaglutide obesity trial
TrialPrimary trial source for semaglutide 2.4 mg weight-loss expectations and side effects.
SURMOUNT-1 tirzepatide obesity trial
TrialPrimary trial source for tirzepatide weight-loss expectations and dose-response ranges.
PubMed evidence trail
Research sources used to frame this page
For FormBlends vs Hims vs Ro: Three Top GLP-1 Telehealth Platforms Compared Side by Side, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Systematic reviewGLP-1 class evidence2025
Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference
A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.
PubMed
Systematic reviewGLP-1 class evidence2025
Discontinuing glucagon-like peptide-1 receptor agonists and body habitus
Used for pages discussing stopping therapy, weight regain, and long-term planning.
PubMed
Systematic reviewGLP-1 class evidence2025
Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition
Supports body-composition, lean-mass, and metabolic-risk context.
PubMed
Comparison decision path
Use this comparison to narrow the provider review question
Direct answer
FormBlends vs Hims vs Ro: Three Top GLP-1 Telehealth Platforms Compared Side by Side should help you decide which option deserves a clinical review, not force a one-size answer.
Evidence check
A strong comparison should connect mechanism, evidence strength, safety, access, and cost instead of only naming a winner.
Safety check
The right choice can change based on history, medication interactions, side effects, budget, and availability.
Next step
After comparing, use the get-started flow to route your goals and health history into the right prescription review path.
FormBlends Editorial Context
Reviewed May 14, 2026Compare FormBlends, Hims & Ro for GLP-1 weight loss. Detailed analysis of pricing, medications, doctor access & patient outcomes. Find your best option. Read "FormBlends vs Hims vs Ro: Three Top GLP-1 Telehealth Platforms Compared Side by Side" as a comparison page where the details that matter most are access, cost, clinical fit, and what a licensed clinician should confirm. The main job of this page is comparison and decision support, especially where the topic touches cost and coverage, provider access. Because this article has 12 major sections, scan the headings first and then use the FAQ or summary sections to pressure-test the answer. Use it to ask sharper questions of a licensed clinician, not as a substitute for personal medical advice.
- Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
- Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
- Verify total monthly cost, refill timing, dose escalation pricing, and what is included before paying.
Original tools and data
Use the FormBlends research stack
These assets are built to be useful beyond a single article: shareable data pages, calculators, provider comparisons, and safety checks that give Google and readers something original to crawl.
Editorial refresh
Practical 2026 note for FormBlends vs Hims vs Ro
This update makes FormBlends vs Hims vs Ro more specific by tying semaglutide, tirzepatide, cash-pay pricing, safety signals, formblends, hims to the page's original clinical, cost, access, or comparison angle.
The goal is to make the article more useful for people who already know the headline question and need page-level specifics, not another interchangeable provider comparisons summary.
For 2026 review, the content emphasizes current verification, treatment fit, and patient-safety questions that can be discussed with a qualified provider.
Custom 2026 image for FormBlends vs Hims vs Ro, provider comparisons, and better treatment decision-making.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.
Disclosure: FormBlends is one of the providers discussed in this article. Our editorial team independently researches and verifies all pricing and claims. Pricing was last verified in March 2026. Read our editorial policy.
Written by FormBlends Editorial Research
Prepared by FormBlends Editorial Research. Claims are checked against primary regulatory, trial, label, and public-health sources where available. Reviewed by FormBlends Medical Team for medical accuracy, sourcing, and patient-safety framing.